Related Experiment Video
Updated: Mar 28, 2026

Identification of Coding and Non-coding RNA Classes Expressed in Swine Whole Blood
Published on: November 28, 2018
Transcriptomic data of piglet blood compartments with 3' mRNA sequencing
Gaëlle Payros1, Kory Jason1, Laure Gress2
1Toxalim, Université de Toulouse, INRAE, ENVT, EI-Purpan, Toulouse, France.
Abstract:
This article reports transcriptomic dataset generated by rationalized sequencing of the 3' ends of messenger RNAs (3' mRNA-Seq) in porcine samples. Libraries were prepared from whole blood, plasma, serum, and exosome-enriched fractions derived from plasma and serum. This approach was applied to whole blood, with porcine globin blockers being used to minimise the impact of the large quantity of globin transcripts. In addition, serum and plasma-derived RNA were processed without globin depletion, allowing a direct assessment of transcriptome profiles from these biofluids. Although the library preparation protocol employed was not originally designed for plasma or serum samples, we successfully produced libraries from RNA extracted from these different compartments. More unexpectedly, libraries could also be generated from exosome-enriched fractions. While expression profiles from plasma and serum fractions display distinctive characteristics compared to whole blood, a quite high proportion of genes were detected in these extracts. The resulting data provide comprehensive transcriptomic information across multiple sample types, including minimally invasive compartments, and are made available to support further exploration of 3' mRNA-Seq in biomedical and veterinary research.
Related Concept Videos
Ribosome Profiling
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique...
RNA-seq
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...

